Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Stem Cell Research
Stem Cell Action Coalition Opposes Virginia Personhood Bill
Posted: Published on February 23rd, 2012
To: HEALTH, MEDICAL AND POLITICAL EDITORS WASHINGTON, Feb. 23, 2012 /PRNewswire-USNewswire/ -- The Stem Cell Action Coalition opposes Virginia House Bill No.1, the so-called Virginia "personhood bill." The Virginia Senate Committee on Education and Health is scheduled to take the matter up this week. The language of the personhood bill states, in part, that the laws of Virginia "shall be interpreted and construed to acknowledge on behalf of unborn children at every stage of development all of the rights, privileges and immunities available to other persons, citizens and residents." The bill further states "unborn children shall include the offspring of human beings from the moment of conception until birth at every stage of biological development." HB 1 arguably would apply to every aspect of Virginia law thus profoundly impacting inheritance, adoption, guardianship, civil and criminal liability by according the same rights as adults and children to a single cell. The personhood bill would surely interfere with reproductive and related rights of women and couples along several fronts. These interferences include making it exceedingly difficult for couples in Virginia to seek in vitro fertilization as a means of creating families and donating for research IVF-created embryos not needed for implantation or … Continue reading
Posted in Stem Cell Research
Comments Off on Stem Cell Action Coalition Opposes Virginia Personhood Bill
Surgeons Urge Caution: Stem Cell Treatments Untested in Aesthetic Surgery
Posted: Published on February 23rd, 2012
Doctors Haeck, Eaves, and Rohrich write joint ASAPS/ASPS statement calling for more research into stem cell facelift and stem cell breast augmentation. Dallas, TX (PRWEB) February 22, 2012 There is little evidence to support the safety and effectiveness of procedures, equipment and treatments that have been advertised using adult stem cells for aesthetic reconstruction, including plastic surgery and facial rejuvenation, according to physicians writing in Plastic and Reconstructive Surgery. Dr. Rod J. Rohrich, chairman of the Department of Plastic Surgery at UT Southwestern Medical Center and editor-in-chief of the journal, published a position statement on “stem cell facelifts” and “stem cell breast augmentation,” also known as “natural breast augmentation.” Dr. Felmont F. Eaves III of Chapel Hill, N.C., and Dr. Phillip C. Haeck of Seattle, Wash.,collaborated on the statement on behalf of the American Society for Aesthetic Plastic Surgery (ASAPS) and the American Society of Plastic Surgeons (ASPS). “There are encouraging data from studies in laboratories to suggest that the use of adult stem cells is a very promising field and may produce beneficial medical therapies to treat a variety of diseases,” the doctors said in the statement. They emphasized that there is a lack of consistency in the way … Continue reading
Posted in Stem Cell Research
Comments Off on Surgeons Urge Caution: Stem Cell Treatments Untested in Aesthetic Surgery
Cancer Stem Cell Research Drives Growth in RBCC’s Target Market
Posted: Published on February 22nd, 2012
NOKOMIS, Fla.--(BUSINESS WIRE)-- Research into Cancer Stem Cells (CSC) is on the rise, fueling industry growth that Rainbow Coral Corp. (OTCBB: RBCC.OB - News) expects to translate into demand for n3D cell growth technologies. RBCC is finalizing an equity funding agreement with n3D Biosciences, the maker of a revolutionary new system that allows scientists to grow three-dimensional cell cultures more easily than ever before. The device, called the Bio-Assembler, could have an extraordinary impact on cell research worldwide, and RBCC expects to find a strong market for the device once its funding agreement with n3D is finalized. Many cancers, including breast, prostate, pancreatic, colon, brain, and lung cancers, contain a subset of stem-like cells understood to play a critical role in the development and progression of the disease. Research suggests that these cells, called Cancer Stem Cells, are able to “seed” new tumor formation and drive metastasis. Because these cells are believed to be at the root of the development and spread of cancer, they’re quickly becoming the center of cancer diagnostics and biomarkers. CSCs are resistant to a number of chemotherapy drugs and radiotherapy, and approximately 20 different strategies are currently being pursued in the hope of selectively targeting … Continue reading
Posted in Stem Cell Research
Comments Off on Cancer Stem Cell Research Drives Growth in RBCC’s Target Market
Qatari students to present research on stem cells
Posted: Published on February 22nd, 2012
Research on the potential of stem cells in preventing ovarian cancer, obesity-related diseases and other serious illnesses affecting people in Qatar and the region is to be presented by three Qatari graduate students at the Qatar International Conference on Stem Cell Science and Policy next week. The conference is organised by Qatar Foundation for Education, Science and Community Development (QF) and James A Baker III Institute for Public Policy. It will provide an international platform to discuss the latest discoveries in stem cell research and collaborate on new therapeutic approaches for the use of stem cells, within an acceptable ethics, cultural and religious framework. The students are part of QF’s Qatar Science Leadership Programme (QSLP), and their participation in the conference is considered an important part of their training. With more than 400 registered participants, including key ethicists and scientists in stem cell research, the conference provides students invaluable opportunities for exchanging knowledge and building relationships with top figures and leading regional and international institutions in the field. QSLP, aims to equip rising Qatari generations for leading roles in the country’s scientific and research endeavours, with stem cell research as a national priority. Qatari QSLP trainee and PhD student from … Continue reading
Posted in Stem Cell Research
Comments Off on Qatari students to present research on stem cells
Stem cell implants boost monkeys with Parkinson's
Posted: Published on February 22nd, 2012
Monkeys suffering from Parkinson's disease show a marked improvement when human embryonic stem cells are implanted in their brains, in what a Japanese researcher said Wednesday was a world first. A team of scientists transplanted the stem cells into four primates that were suffering from the debilitating disease. The monkeys all had violent shaking in their limbs -- a classic symptom of Parkinson's disease -- and were unable to control their bodies, but began to show improvements in their motor control after about three months, Kyoto University associate professor Jun Takahashi told AFP. About six months after the transplant, the creatures were able to walk around their cages, he said. "Clear improvements were confirmed in their movement," he said. Parkinson's disease is a progressive neurological illness linked to a decrease in dopamine production in the brain. There is currently no medical solution to this drop off in a key neurotransmitter. The condition, which generally affects older people, gained wider public recognition when Hollywood actor Michael J. Fox revealed he was a sufferer. Takahashi said at the time of the implant about 35 percent of the stem cells had already grown into dopamine neuron cells, with around 10 percent still alive … Continue reading
Posted in Stem Cell Research
Comments Off on Stem cell implants boost monkeys with Parkinson's
Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
Posted: Published on February 21st, 2012
A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. "Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety," which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid arthritis patients who were treated with their own fat-derived stem cells. Dallas, TX (PRWEB) February 21, 2012 A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. "Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety," which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid arthritis patients who were treated with their own fat-derived stem cells. Treating arthritis with fat-derived stem cells has become commonplace in veterinary medicine over the past five years with over 7,000 horses and dogs treated by publication contributor Vet-Stem, a San Diego-based company. The objective of the joint Panamanian-US study was to determine feasibility of translating Vet-Stem's successful animal results into human patients. Observing no treatment associated adverse reactions after one year, the team concluded that its protocol should be studied further to determine efficacy … Continue reading
Posted in Stem Cell Research
Comments Off on Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
Editor’s move sparks backlash
Posted: Published on February 21st, 2012
Bioethicist Glenn McGee’s new job raised questions of conflict of interest at the journal he founded. J. WILSON/KRT/NEWSCOM The field of bioethics is embroiled in a period of soul-searching, sparked by a startling career move by one of its biggest names. Glenn McGee is the editor-in-chief of the American Journal of Bioethics (AJOB), the most cited bioethics journal, which he founded in 1999. Since December 2011, he has also been president for ethics and strategic initiatives at CellTex Therapeutics in Houston, Texas, a controversial company involved in providing customers with unproven stem-cell therapies. A CellTex press release says that “Dr McGee’s responsibilities will include ensuring that all of the firm’s work, centered on adult stem cells, will meet the highest ethical standards of the medical and scientific communities.” Although McGee has said he will leave the journal on 1 March, many bioethicists have criticized him, the journal’s editorial board and its publisher, London-based Taylor and Francis. They argue that in holding both posts, McGee has a conflict of interest between his responsibilities to the journal and his new employer’s desire to promote the clinical application of stem-cell treatments that are not approved by the US Food and Drug Administration. “Imagine … Continue reading
Posted in Stem Cell Research
Comments Off on Editor’s move sparks backlash
Sigma® Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio, Deepens Commitment to …
Posted: Published on February 21st, 2012
ST. LOUIS, Mo., Feb. 21, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, has furthered its commitment to stem cell research, drug discovery and ADME/Toxicology by acquiring a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio. Sigma Life Science, leveraging its zinc finger protein platform and stem cell technology portfolio, is now poised to develop a new set of differentiated tools for both the drug discovery and preclinical research communities. These tools will include novel iPS-cells, iPS-cell derived primary cells, novel assays, custom cell line development and ADME/Toxicology services. Under the terms of the agreement, iPS Academia Japan, Inc. (AJ) will receive a license fee from Sigma-Aldrich. iPS cell technology can create pluripotent stem cells from the normal adult cells of a patient. Pluripotent stem cells are capable of differentiating into many specialized primary cell types needed for research, such as cardiomyocytes, hepatocytes, neurons, and muscle cells. With access to differentiated cells from patients with the condition of interest, or healthy human cells engineered to contain disease-specific genetics, researchers may obtain greater predictive accuracy than is possible with the in vitro models used … Continue reading
Posted in Stem Cell Research
Comments Off on Sigma® Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio, Deepens Commitment to …
Takes Nerve UCI Stem Cell Research PSA – Video
Posted: Published on February 21st, 2012
10-02-2012 10:12 Join athletes, artists, scientists, entrepreneurs, activists, students and the University of California Irvine in advocating for game-changing stem cell research. Stem cells are the building blocks for all other human cells. Better, safer drugs and new treatments are already in development that could one day enable the paralyzed to walk again and the blind to see. Stem cells offer hope for millions of people around the world suffering form cancer, heart disease, stroke, diabetes, Parkinson's, Huntington's, Alzheimer's, HIV/Aids, multiple sclerosis and countless other diseases. This is our moment. Please support stem cell research. Original post: Takes Nerve UCI Stem Cell Research PSA - Video … Continue reading
Posted in Stem Cell Research
Comments Off on Takes Nerve UCI Stem Cell Research PSA – Video
University of Michigan Stem Cell Research – Video
Posted: Published on February 21st, 2012
17-02-2012 08:37 The University of Michigan is doing advanced stem cell research using laboratory produced embryos which are due to be discarded. This research is an integral part of developing a stem cell strategy to treat chronic diseases. Read more: University of Michigan Stem Cell Research - Video … Continue reading
Posted in Stem Cell Research
Comments Off on University of Michigan Stem Cell Research – Video
We cordially invite you to collaborate with us (as Speaker/Exhibitor/Sponsor/Media Partner) for “10th Annual Conference on Stem Cell and Regenerative Medicine” scheduled on August 13-14, 2018 in London, UK.
For meeting details visit: https://stemcell-regenerativemedicine.conferenceseries.com/